The year 2022 was a productive and promising year for Alzheimer’s research, including discoveries related to the causes, risk factors and treatment of Alzheimer’s disease and other …
Join our family of readers for as little as $5 per month and support local, unbiased journalism.
Already a member? Log in to continue. Otherwise, follow the link below to join.
Please log in to continue |
The year 2022 was a productive and promising year for Alzheimer’s research, including discoveries related to the causes, risk factors and treatment of Alzheimer’s disease and other dementias.
Here are five important things learned about Alzheimer’s in 2022 from the Delaware Valley chapter of the Alzheimer’s Association:
This data appeared five months after the FDA announced it will allow hearing aids to be sold over the counter, greatly expanding access to 30 million Americans living with hearing loss. In addition to improving daily communication, use of hearing aids may also benefit brain health.
“With each new study, we learn more and more about the brain, dementia and the various ways we can proactively improve overall brain health, protect cognition and ultimately change the course of the disease,” said Linda Barba, Alzheimer’s Association Delaware Valley Chapter research champion. “These are important findings not only for the 19,000 Delawareans living with dementia and their 47,000 family caregivers—but for the general public as well.”
While advancements are happening, the significant impact of Alzheimer’s remains. Over a recent 20-year period, deaths from heart disease went down 7.3%, while deaths from Alzheimer’s increased 145%. In 2022, Alzheimer’s and other dementias will cost the nation $321 billion.
“With several FDA decisions expected on Alzheimer’s treatments in 2023, this is a very exciting time in the fight to end this disease. Thanks to increased research funding from the federal government and nonprofit organizations there is great hope, and the new year is sure to bring more advances and discoveries for people living with, and at risk for, Alzheimer’s disease and all other dementia,” Ms. Barba said.
To learn more about these developments and for other disease information and resources, visit alz.org or call the Alzheimer’s Association 24/7 Helpline at 800-272-3900.